Laura S Blackwell1, Margaret Martinez2, Ashley Fournier-Goodnight3, Janet Figueroa4, Andrew Appert3, Atul Vats5, Bushra Wali6, Iqbal Sayeed6, Andrew Reisner3. 1. Department of Neuropsychology, Children's Healthcare of Atlanta, Atlanta, GA. Electronic address: laura.blackwell@choa.org. 2. Rowan School of Osteopathic Medicine, Stratford, NJ. 3. Department of Neuropsychology, Children's Healthcare of Atlanta, Atlanta, GA. 4. Emory University School of Medicine, Atlanta, GA. 5. Department of Neuropsychology, Children's Healthcare of Atlanta, Atlanta, GA; Department of Pediatrics, Emory School of Medicine, Atlanta, GA. 6. Department of Emergency Medicine, Emory School of Medicine, Atlanta, GA.
Abstract
OBJECTIVE: To examine levels of plasma osteopontin (OPN), a recently described neuroinflammatory biomarker, in children with abusive head trauma (AHT) compared with children with other types of traumatic brain injury (TBI). STUDY DESIGN: The study cohort comprised children aged <4 years diagnosed with TBI and seen in the intensive care unit in a tertiary children's hospital. Patients were classified as having confirmed or suspected AHT or TBI by other mechanisms (eg, motor vehicle accidents), as identified by a Child Protection Team clinician. Serial blood samples were collected at admission and at 24, 48, and 72 hours after admission. Levels of OPN were compared across groups. RESULTS: Of 77 patients identified, 24 had confirmed AHT, 12 had suspected AHT, and 41 had TBI. There were no differences in the Glasgow Coma Scale score between the patients with confirmed AHT and those with suspected AHT and those with TBI (median score, 4.5 vs 4 and 7; P = .39). At admission to the emergency department, OPN levels were significantly higher in children with confirmed AHT compared with the other 2 groups (mean confirmed AHT, 471.5 ng/mL; median suspected AHT, 322.3 ng/mL; mean TBI, 278.0 ng/mL; P = .03). Furthermore, the adjusted mean trajectory levels of OPN were significantly higher in the confirmed AHT group compared with the other 2 groups across all subsequent time points (P = <.01). CONCLUSIONS: OPN is significantly elevated in children with confirmed AHT compared with those with suspected AHT and those with other types of TBI. OPN expression may help identify children with suspected AHT to aid resource stratification and triage of appropriate interventions for children who are potential victims of abuse.
OBJECTIVE: To examine levels of plasma osteopontin (OPN), a recently described neuroinflammatory biomarker, in children with abusive head trauma (AHT) compared with children with other types of traumatic brain injury (TBI). STUDY DESIGN: The study cohort comprised children aged <4 years diagnosed with TBI and seen in the intensive care unit in a tertiary children's hospital. Patients were classified as having confirmed or suspected AHT or TBI by other mechanisms (eg, motor vehicle accidents), as identified by a Child Protection Team clinician. Serial blood samples were collected at admission and at 24, 48, and 72 hours after admission. Levels of OPN were compared across groups. RESULTS: Of 77 patients identified, 24 had confirmed AHT, 12 had suspected AHT, and 41 had TBI. There were no differences in the Glasgow Coma Scale score between the patients with confirmed AHT and those with suspected AHT and those with TBI (median score, 4.5 vs 4 and 7; P = .39). At admission to the emergency department, OPN levels were significantly higher in children with confirmed AHT compared with the other 2 groups (mean confirmed AHT, 471.5 ng/mL; median suspected AHT, 322.3 ng/mL; mean TBI, 278.0 ng/mL; P = .03). Furthermore, the adjusted mean trajectory levels of OPN were significantly higher in the confirmed AHT group compared with the other 2 groups across all subsequent time points (P = <.01). CONCLUSIONS:OPN is significantly elevated in children with confirmed AHT compared with those with suspected AHT and those with other types of TBI. OPN expression may help identify children with suspected AHT to aid resource stratification and triage of appropriate interventions for children who are potential victims of abuse.
Authors: Hector A Olvera Alvarez; Laura D Kubzansky; Matthew J Campen; George M Slavich Journal: Neurosci Biobehav Rev Date: 2018-06-03 Impact factor: 8.989
Authors: Rachel Pardes Berger; Tina Dulani; P David Adelson; John M Leventhal; Rudolph Richichi; Patrick M Kochanek Journal: Pediatrics Date: 2006-02 Impact factor: 7.124
Authors: Rachel Pardes Berger; Brian J Pak; Mariya D Kolesnikova; Janet Fromkin; Richard Saladino; Bruce E Herman; Mary Clyde Pierce; David Englert; Paul T Smith; Patrick M Kochanek Journal: JAMA Pediatr Date: 2017-06-05 Impact factor: 16.193
Authors: Heather T Keenan; Desmond K Runyan; Stephen W Marshall; Mary Alice Nocera; David F Merten; Sara H Sinal Journal: JAMA Date: 2003-08-06 Impact factor: 56.272
Authors: Idan Shalev; Waylon J Hastings; Laura Etzel; Salomon Israel; Michael A Russell; Kelsie A Hendrick; Megan Zinobile; Sue Rutherford Siegel Journal: PLoS One Date: 2020-04-03 Impact factor: 3.240
Authors: Andrew Reisner; Laura S Blackwell; Iqbal Sayeed; Hannah E Myers; Bushra Wali; Stacy Heilman; Janet Figueroa; Austin Lu; Laila Hussaini; Evan J Anderson; Andi L Shane; Christina A Rostad Journal: Exp Biol Med (Maywood) Date: 2021-09-26